BC
MYOV

Blackcrane Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Blackcrane Capital’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-139,552
Closed -$2.17M – 13
2021
Q4 		$2.17M Buy
139,552
+8,458
+6% +$161K 3.02% 9
2021
Q3 		$2.94M Buy
131,094
+3,425
+3% +$75.2K 3.75% 9
2021
Q2 		$2.91M Sell
127,669
-14,396
-10% -$303K 3.55% 10
2021
Q1 		$2.92M Buy
142,065
+72,370
+104% +$1.65M 4.61% 8
2020
Q4 		$1.93M Buy
+69,695
New +$1.36M 3.78% 8

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Blackcrane Capital's MYOV Position: Q1 2022 in Review

Blackcrane Capital sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 139,552 shares — an estimated $2.17M sold.

Blackcrane Capital first reported a position in MYOV in Q4 2020 and held it in 5 quarters. The position peaked at $2.94M in Q3 2021. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

  • Blackcrane Capital reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
  • Blackcrane Capital sold 139,552 Myovant Sciences Ltd. shares in Q1 2022, an estimated $2.17M.
  • Blackcrane Capital first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 5 quarters.
  • Blackcrane Capital's Myovant Sciences Ltd. position peaked at $2.94M in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Blackcrane Capital's 13F filing for Q1 2022, filed 12 May 2022.